Panel Discussion: Exploring Opportunities in Alpha-Synuclein & Beyond for More Transformative & Efficacious Therapies: What’s Coming Next in Parkinson’s Drug Development?
Time: 4:30 pm
day: Conference Day One PM
Details:
- Overview of trehalose and its effects as a modulator of autophagy
- Pharmacokinetics and brain penetration of trehalose in rodents and non-human primates
- Lowering the therapeutic dose of trehalose and moving into clinical development
